TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients

The potency of human papillomavirus type 16 (HPV16)-encoded synthetic long peptides (SLP), conjugated to an optimized Toll-like receptor 2 ligand (TLR2-L), was assessed in ex vivo activation of HPV16(+) cancer patient-derived T cells. Two highly immunogenic SLP sequences derived from the oncogenic E...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Zom, Gijs G., Welters, Marij J.P., Loof, Nikki M., Goedemans, Renske, Lougheed, Sinéad, Valentijn, Rob R.P.M., Zandvliet, Maarten L., Meeuwenoord, Nico J., Melief, Cornelis J.M., de Gruijl, Tanja D., Van der Marel, Gijsbert A., Filippov, Dmitri V., Ossendorp, Ferry, Van der Burg, Sjoerd H.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5341859/
https://ncbi.nlm.nih.gov/pubmed/27564262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11512
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia